Status:

COMPLETED

A Psychophysiologic Study of Weakening Traumatic Combat Memories With Post-Reactivation Propranolol

Lead Sponsor:

Massachusetts General Hospital

Collaborating Sponsors:

VA Office of Research and Development

Conditions:

Posttraumatic Stress Disorder

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

The consolidation of learning is enhanced by adrenalin and other stress hormones. This memory enhancing effect is opposed by propranolol. In posttraumatic stress disorder (PTSD), a psychologically tra...

Detailed Description

Background: Animal evidence indicates that some consolidated memories when reactivated (retrieved) need to be reconsolidated. During this process, memories can be enhanced or weakened. In a preliminar...

Eligibility Criteria

Inclusion

  • Afghanistan and Iraq War veterans who have been diagnosed as having combat-related PTSD

Exclusion

  • PTSD Checklist (PCL) score (administered at the referring site) ≤ 50;
  • Current, co-existing PTSD of non-combat origin
  • Resting systolic blood pressure \<100 mm Hg
  • Medical condition that contraindicates the administration of propranolol
  • Previous adverse reaction to, or non-compliance with, a β-adrenergic blocker
  • Presence of drugs of abuse
  • Pregnancy
  • Contraindicating psychiatric condition
  • Initiation of, or change in, psychotropic medication within the two months prior to recruitment
  • Current use of medication that may involve potentially dangerous interactions with propranolol
  • Inability to understand the study's procedures, risks, and side effects, or to otherwise give informed consent for participation
  • Does not understand English

Key Trial Info

Start Date :

May 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2010

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT00709735

Start Date

May 1 2007

End Date

August 1 2010

Last Update

April 10 2017

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

VA Medical Center

Bedford, Massachusetts, United States, 01730

2

Massachusetts General Hospital

Boston, Massachusetts, United States, 02108

3

VA Medical Center

Manchester, New Hampshire, United States, 03104